Notice of Adjourned General Meeting
09/03/2023 14:00
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230309:nRSI4811Sa&default-theme=true
RNS Number : 4811S Zamaz PLC 09 March 2023
9 March 2023
Zamaz plc
("Zamaz" or "the Company")
Adjournment of a Meeting of the holders of the Company's EUR 3,000,000 6%
Fixed Rate Bonds due 30 April 2023 (ISIN GB00BL96TV97)
&
Notice of re-convened Meeting
On 17 February 2023, Zamaz plc (LSE: ZAMZ), the London-based international
e-commerce and retail technology aggregator of sustainable brands, announced
that it was convening a meeting of the holders of the Company's EUR
3,000,000 6% Fixed Rate Bonds due 30 April 2023 ("the 6% Bonds"), ISIN
GB00BL96TV97, to be held at 9.00am, today, 9 March 2023.
The Meeting was, however, not deemed quorate under the Terms and Conditions of
the Bond Instrument and was adjourned. It has been reconvened for 9.00 am on
21 March 2023 at 50, Sloane Avenue, London, SW3 3DD.
The notice of reconvened meeting, together with an amended Consent
Solicitation Memorandum, is being sent to bondholders today. The notice
requests bondholders to consider and, if thought fit, approve a proposal to
modify the terms and conditions of the 6% Bonds by way of an extraordinary
resolution.
The extraordinary resolution to be put to bondholders seeks approval for:
· the maturity of the 6% Bonds to be extended to 30 April 2026 from 30
April 2023; and
· an increase in the Nominal Value of the bonds to up to € 15,000,000
from € 3,000,000; and
· the Rate of Interest to be increased to 7.5 per cent. from 6.0 per
cent per annum.
Should the changes be approved, bondholders will be issued warrants to
subscribe for new Zamaz shares in an amount equal to the par value of bonds
held at the time of grant of the warrants divided by the £0.11 strike price
of the warrant, plus a further number of Zamaz shares at a deemed issue price
of nominal value, representing a 10% conversion premium. The duration of the
warrants will be three years from the implementation date. They will be
fully transferrable.
The Company will issue a further announcement on the outcome of the
bondholders' reconvened meeting following its conclusion.
This announcement contains inside information for the purposes of the UK
Market Abuse Regulation and the Directors of the Company are responsible for
the release of this announcement.
Zamaz plc
Martin Groak, Chairman info@zamaz.tech
c/o Walbrook PR Limited
Walbrook PR Limited +44 20 7933 8780 or +44 07 768807631
Paul Vann/Nick Rome/Joe Walker zamaz@walbrookpr.com
About Zamaz plc:
Zamaz plc is a technology driven e-commerce business that originates, acquires
or licenses, operates and scales small and medium-sized brands with
category-winning products on global marketplaces. With ever prolific customer
data sources, the advent of turnkey e-commerce website platforms, such as
Shopify, and a thriving ecosystem of third-party software integrators, the
options available to launch and build brands that can be marketed, sold, and
shipped online quickly and globally with limited risk have never been more
compelling. Such marketplaces, led by Amazon and eBay, also provide connection
to millions of consumers, and have become a first-choice route-to-market for a
generation of micro and small and medium-sized enterprise businesses.
Zamaz mines and analyses data from such online retail technology platforms
which provide significant insights into consumer shopping behaviour and trends
and enable the business to deploy, market and sell an optimised portfolio of
brands, products, packs and prices aligned with active, real-time consumer
needs and demands principally on UK and EU Amazon marketplaces.
About Bella Dispensa:
Bella Dispensa, a wholly-owned subsidiary of Zamaz, is an Italian-based online
retailer of gourmet Italian food products which operates in one of the fastest
growing online sectors, grocery shopping. The extensive relationships that
Bella Dispensa enjoys with its niche food suppliers makes it a strong addition
to the Zamaz Brand Portfolio and will give Zamaz the opportunity to showcase
and sell Bella Dispensa sourced products on its online platform.
Bella Dispensa has already made three acquisitions since Zamaz listed on the
Main Market of the London Stock Exchange; the first two in H2 2022: Ecocarni,
a purveyor of premium quality meats and associated products sourced from Italy
and Argentina to both wholesale and retail customers, from its flagship store
in Milan and Eccellenze S.r.l. which has a retail store located on Milan's
prestigious Corso Venezia, one of the city's most exclusive and elegant
avenues, being part of the upscale Quadrilatero della moda shopping district.
Recently established in Q4 2021, Eccellenze has grown rapidly, and now offers
over 1,000 premium quality food products in-store, including cheese, pasta,
wine and oil. Its highly experienced management team has also developed a
unique eno-gastronomic "lifestyle shopping experience" for its growing, highly
discerning client base.
Most recently, Bella Dispensa has acquired Dallate Italia srl. Dallatte,
based in Piedmont, Italy, is a manufacturer and distributor of premium dairy
products using natural ingredients including ice cream and pastries, milk,
butter and cooking cream, fresh and dry pastries and frozen filled pasta. The
Dallatte brand is synonymous with "Italian Food Excellence" and has
distribution outlets across Europe.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NOGFLFVVVRIAIIV